Drug firm lupin last month said that the US health regulator has issued a Form-483 with ten observations after inspecting its Pithampur (Indore) Unit-2 between 21 March and 29 March 2023. The number of inspection observations is high and compares to six observations that were issued following the inspection at the facility in January 2019. […]
